Abiopharma

Johnson & Johnson - RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) prevents acquired resistance versus osimertinib in first-line EGFR-mutated non-small cell lung cancer

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) prevents acquired resistance versus osimertinib in first-line EGFR-mutated non-small cell lung cancer

Garden Stage Limited - Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

UNCY Investors: If you Lost Significant Money in UNCY Contact Robbins LLP for Information About the Securities Fraud Class Action Against Unicycive Therapeutics, Inc.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Colabor Group Inc. Announces Forbearance Agreements with Principal Lenders and Investissement Québec

Groupe Colabor Inc. annonce des conventions de tolérance avec les prêteurs principaux et Investissement Québec

SCHEDULE 13D/A - Ancora Alternatives LLC (0001836192) (Filed by)

SCHEDULE 13D/A - Green Plains Inc. (0001309402) (Subject)

4 - Jeremy Scott TTEE, Jeremy Scott Revocable Trust Dtd 6/25/15 (0001909124) (Reporting)

4 - Scott Jeremy (0001803925) (Reporting)

4 - NBAR5 Limited Partnership (0002076804) (Reporting)

4 - FIRST INTERSTATE BANCSYSTEM INC (0000860413) (Issuer)

Rodino-Klapac Louise 🟢 acquired 143.9K shares of Sarepta Therapeutics, Inc. (SRPT) Transaction Date: Sep 03, 2025 | Filing ID: 197425